Results 91 to 100 of about 61,573 (234)
Penetration of Piperacillin/Tazobactam Into Gynecologic Tissues Following a Single Loading Dose Prior to Hysterectomy [PDF]
Objective: This study was undertaken to determine plasma and pelvic tissue concentrations of piperacillin/tazobactam following a single intravenous administration.Methods: Plasma and tissue samples were obtained following administration of 3 g of ...
O\u27Brien, William F. +3 more
core +1 more source
Abstract The primary objective is to critically analyze approaches to local therapy for periodontal disease, particularly in light of its well‐established systemic implications. We specifically address common misconceptions and overestimations regarding the potential of local treatments in contrast to their actual clinical effectiveness.
Andrea Mombelli, Alkisti Zekeridou
wiley +1 more source
Novel and emerging antimicrobial strategies in the management of oral infections
Abstract Background Antibiotics marked a pivotal turning point in human civilization, enhancing social interactions and extending human life expectancy. In addition to their success in treating systemic infectious diseases, they have significantly improved periodontal treatment outcomes as an adjunct therapy.
Ozge Unlu, Nil Yakar, Alpdogan Kantarci
wiley +1 more source
Introduction: Antimicrobial resistance is a growing global concern. At our hospital, susceptibility of Pseudomonas aeruginosa to piperacillin-tazobactam declined from 95% to 77%, while susceptibility of Enterobacter cloacae complex decreased from 82% to ...
Ivayla I. Geneva +3 more
doaj +1 more source
Effectiveness of nonsurgical therapy of peri‐implant mucositis: A systematic review
Abstract Objectives This systematic review intends to respond to the question: “How do clinical parameters change in implants affected by peri‐implant mucositis following different non‐surgical treatment approaches or no treatment in patients monitored for a minimum of six months?” Materials and Methods A search for randomized clinical trials (RCTs) or
Giulia Brunello +4 more
wiley +1 more source
Objectives: To provide a descriptive analysis of the in vitro antimicrobial susceptibility testing results for all 39,661 Pseudomonas aeruginosa isolates collected by the ATLAS global surveillance programme data from 2020 to 2024 with a focus on ...
Mark A. Estabrook +3 more
doaj +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nadine Larissa Fergen +4 more
wiley +1 more source
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez +16 more
wiley +1 more source
This study evaluated the in vitro activity of ceftolozane-tazobactam and comparator agents tested against Latin American isolates of Enterobacteriaceae and Pseudomonas aeruginosa from patients with health care-associated infections.
Michael A. Pfaller +5 more
doaj +1 more source
Background Haemophilus influenzae (Hi) is a Gram-negative bacterium that may cause sepsis or meningitis, treatment of which mainly includes β-lactam antibiotics. Since 2019 EUCAST breakpoints for piperacillin/tazobactam have been available.
Claus, Heike +3 more
core +1 more source

